| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/03/2003 | WO2003001195A1 Monitoring of gas sensors |
| 01/03/2003 | WO2003001194A1 Extracellular recording electrode |
| 01/03/2003 | WO2003001191A2 Monitoring of gas sensors |
| 01/03/2003 | WO2003001182A2 Homocysteinylated transthyretin |
| 01/03/2003 | WO2003001178A2 Configurable dynamic three dimensional array |
| 01/03/2003 | WO2003000931A1 Immunoaffinity isolation of modified peptides from complex mixtures |
| 01/03/2003 | WO2003000928A2 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 01/03/2003 | WO2003000925A1 Methods to identify signal sequences |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000891A2 Protein-protein interactions in the inner ear |
| 01/03/2003 | WO2003000889A2 Identification of ses-1 and the uses of the same |
| 01/03/2003 | WO2003000887A1 Polynucleotide probe and primer originating in hepatitis e virus of japanese, chips having the same, kits having the same and method of detecting hepatitis e virus using the same |
| 01/03/2003 | WO2003000878A2 Use of fkbp chaperones as expression tool |
| 01/03/2003 | WO2003000877A2 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | WO2003000872A1 Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same |
| 01/03/2003 | WO2003000869A1 Transgenic animals and cells expressing proteins necessary for susceptibility to hiv infection |
| 01/03/2003 | WO2003000865A2 Human secreted proteins |
| 01/03/2003 | WO2003000864A2 Nucleic acid-associated proteins |
| 01/03/2003 | WO2003000859A2 G-protein coupled receptors |
| 01/03/2003 | WO2003000853A2 Protein aggregation assays and uses thereof |
| 01/03/2003 | WO2003000848A2 Liver engrafting cells, assays, and uses thereof |
| 01/03/2003 | WO2003000846A2 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | WO2003000845A2 Methods for detection of disease-associated antibodies in urine |
| 01/03/2003 | WO2003000844A2 Protein modification and maintenance molecules |
| 01/03/2003 | WO2003000842A2 Novel proteins and nucleic acids encoding same |
| 01/03/2003 | WO2003000840A2 Nitrilases |
| 01/03/2003 | WO2003000751A1 Endocrine disruptive chemical free additives and method |
| 01/03/2003 | WO2003000748A1 Analysis cards |
| 01/03/2003 | WO2003000732A2 Fragments of the retinoic acid-related orphan receptor (ror) comprising the lig and binding domain (lbd), crystal structure of the lbd of ror-beta and their applications |
| 01/03/2003 | WO2003000731A1 Stereostructural motif and three-dimensional structural coordinate of peptide and utilization thereof |
| 01/03/2003 | WO2003000730A1 Compounds that modulate estrogen actions |
| 01/03/2003 | WO2003000729A2 Secreted polypeptide and their use in the treatment of bone disorders |
| 01/03/2003 | WO2003000727A2 Atopy |
| 01/03/2003 | WO2003000721A2 Mycobacterial antigens expressed under low oxygen tension |
| 01/03/2003 | WO2003000717A2 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 01/03/2003 | WO2003000715A1 Chimeric histone acetyltransferase polypeptides |
| 01/03/2003 | WO2003000478A1 Weighing equipment for concrete material |
| 01/03/2003 | WO2003000433A1 Functional surface coating |
| 01/03/2003 | WO2003000404A1 Matrix screening method |
| 01/03/2003 | WO2003000273A1 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 01/03/2003 | WO2003000271A2 System and method for the large scale labeling of compounds with radiohalogens |
| 01/03/2003 | WO2003000228A2 Method for high through put screening using a small scale mill or microfluidics |
| 01/03/2003 | WO2003000189A2 Prediction, diagnosis and treatment of endocrine resistant breast cancer, using p38 mapk pathway |
| 01/03/2003 | WO2003000119A2 Characterization of fluids using ultrasound |
| 01/03/2003 | WO2003000117A2 Detection and treatment of prostate cancer |
| 01/03/2003 | WO2003000026A2 Integrated automatic blood collection and processing unit |
| 01/03/2003 | WO2003000024A2 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/03/2003 | WO2003000021A2 Pancam nucleic acids and polypeptides |
| 01/03/2003 | WO2003000014A2 Spherical protein particles and methods of making and using them |
| 01/03/2003 | WO2003000012A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer |
| 01/03/2003 | WO2002090945A3 Method of performing an assay, apparatus therefor, and a method of manufacturing and apparatus |
| 01/03/2003 | WO2002090595A9 Methods for modulating an immune response by modulating krc activity |
| 01/03/2003 | WO2002088743A3 Biopolymer marker having a molecular weight of 1097 daltons |
| 01/03/2003 | WO2002088727A3 Biopolymer marker having a molecular weight of 1690 daltons |
| 01/03/2003 | WO2002088725A3 Biopolymer marker having a molecular weight of 1793 daltons |
| 01/03/2003 | WO2002088724A3 Biopolymer marker having a molecular weight of 1896 daltons |
| 01/03/2003 | WO2002088723A3 Biopolymer marker having a molecular weight of 1406 daltons |
| 01/03/2003 | WO2002086149A3 Diagnosis by sensing volatile components |
| 01/03/2003 | WO2002077610A3 Compositions and methods for identifying and using modulators of phosphorylation of alpha integrin subunits |
| 01/03/2003 | WO2002068942A3 An imaging fluorometer for time resolved fluorescence |
| 01/03/2003 | WO2002065133A3 Ligands used for detecting prions |
| 01/03/2003 | WO2002060919A9 Molecules with extended half-lives, compositions and uses thereof |
| 01/03/2003 | WO2002060377A3 The separation, identification and quantitation of protein mixtures |
| 01/03/2003 | WO2002058845A3 Reaction vessel and system incorporating same |
| 01/03/2003 | WO2002051856A3 Method for immobilising probes, in particular for producing biochips |
| 01/03/2003 | WO2002047673A3 Methods and compositions to treat conditions associated with neovascularization |
| 01/03/2003 | WO2002040966A3 Compression test method and apparatus for determining granule strength |
| 01/03/2003 | WO2002033420A3 A urine test for the diagnosis of prion diseases |
| 01/03/2003 | WO2002028891A3 Listeria inocua, genome and applications |
| 01/03/2003 | WO2002024748A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/03/2003 | WO2002020764A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/03/2003 | WO2002020562A3 Family member of inhibitor of apoptosis proteins |
| 01/03/2003 | WO2002016941A3 A combinatorial method for rapid screening of drug delivery formulations |
| 01/03/2003 | WO2002016429A3 Compositions and methods for the diagnosis and treatment of tumor |
| 01/03/2003 | WO2002012501A3 Anti-dual integrin antibodies, compositions, methods and uses |
| 01/03/2003 | WO2002010768A3 Model for alzheimer's disease and other neurodegenerative diseases |
| 01/03/2003 | WO2002010387A3 G-protein coupled receptors |
| 01/03/2003 | WO2002005842A3 Preventing airway mucus production by administration of egf-r antagonists |
| 01/03/2003 | WO2002004611A3 Aminoacyl trna synthetases |
| 01/03/2003 | WO2002003061A2 Method for identifying substances which are suitable to be used for treating virus infections |
| 01/03/2003 | WO2002002757A3 Adenylyl and guanylyl cyclases |
| 01/03/2003 | WO2002002627A3 Interferon-like protein zcyto21 |
| 01/03/2003 | WO2002002603A3 Protein modification and maintenance molecules |
| 01/03/2003 | WO2002002131A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/03/2003 | WO2002000727A3 Gp286 nucleic acids and polypeptides |
| 01/03/2003 | WO2002000724A3 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 01/03/2003 | WO2001098512A3 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 01/03/2003 | WO2001098468A3 Proteases |
| 01/03/2003 | WO2001098357A3 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 01/03/2003 | WO2001094549A9 Methods of differentiating and protecting cells by modulating the p38/mef2 pathway |
| 01/03/2003 | WO2001092528A3 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 01/03/2003 | WO2001081632A9 Methods for monitoring the expression of alternatively spliced genes |
| 01/03/2003 | WO2001081581A9 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 01/03/2003 | WO2001081408A9 G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 01/03/2003 | WO2001075452A9 Detection of nerve damage using marker scip |
| 01/03/2003 | WO2001070002A3 Signal recording of a receptor-effector-system by an extracellular planar potential-sensitive electrode |
| 01/03/2003 | WO2001062959A3 Endometriosis-related markers and uses thereof |
| 01/03/2003 | CA2770453A1 A soluble complex comprising a retroviral surface glycoprotein |
| 01/03/2003 | CA2677781A1 Nitrilases |
| 01/03/2003 | CA2633595A1 Antibodies against tumor-associated antigenic target (tat) polypeptides |